skip to main content

Case

May 14, 2014

Alcon Canada Inc. v. Cobalt Pharmaceuticals Company

Featuring: Peter Wilcox and Marian Wolanski

We successfully defended the validity of Bayer’s key patent covering the anti-infective moxifloxacin (AVELOX® and VIGAMOX ®) and obtained an order prohibiting the Minister of Health from granting marketing approval to Cobalt’s generic product until the expiry of the patent.

Expertise

  • Patents

© 2015 Belmore Neidrauer LLP | Legal Disclaimer | Privacy Policy